Huron Consulting Group (NASDAQ:HURN) updated its FY 2019 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $2.39-2.60 for the period, compared to the Thomson Reuters consensus estimate of $2.39. The company issued revenue guidance of $830-860 million, compared to the consensus revenue estimate of $828.26 million.
Several equities analysts have commented on the stock. ValuEngine downgraded shares of Zosano Pharma from a buy rating to a hold rating in a research note on Wednesday, May 1st. Benchmark restated a buy rating and issued a $120.00 price target (up previously from $110.00) on shares of SPS Commerce in a research note on Thursday, May 2nd. BidaskClub downgraded shares of Westport Fuel Systems from a buy rating to a hold rating in a research note on Friday, July 19th. Barrington Research dropped their price target on shares of CBS from $72.00 to $60.00 and set an outperform rating for the company in a research note on Monday, May 6th. Finally, Zacks Investment Research upgraded shares of DLH from a sell rating to a hold rating in a research note on Tuesday, July 9th. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Huron Consulting Group presently has an average rating of Buy and an average target price of $57.75.
Shares of HURN stock traded down $0.36 on Tuesday, reaching $54.84. 114,319 shares of the stock were exchanged, compared to its average volume of 79,038. The company has a quick ratio of 0.58, a current ratio of 0.58 and a debt-to-equity ratio of 0.15. The company’s 50 day moving average price is $52.23. The stock has a market cap of $1.25 billion, a P/E ratio of 26.37, a price-to-earnings-growth ratio of 1.71 and a beta of -0.04. Huron Consulting Group has a twelve month low of $43.30 and a twelve month high of $57.00.
In related news, Director George Massaro sold 547 shares of the business’s stock in a transaction on Monday, July 1st. The shares were sold at an average price of $50.02, for a total value of $27,360.94. Following the completion of the sale, the director now directly owns 21,999 shares of the company’s stock, valued at $1,100,389.98. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO James H. Roth sold 17,500 shares of the business’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $49.43, for a total transaction of $865,025.00. Following the completion of the sale, the chief executive officer now directly owns 189,212 shares of the company’s stock, valued at $9,352,749.16. The disclosure for this sale can be found here. Insiders own 2.86% of the company’s stock.
Huron Consulting Group Company Profile
Huron Consulting Group Inc, a professional services firm, provides advisory, technology, and analytic solutions in the United States and internationally. Its Healthcare segment provides advisory services in the areas of strategy, care transformation, financial and operational excellence, technology and analytics, and leadership development to national and regional hospitals, integrated health systems, academic medical centers, community hospitals, and medical groups.
Read More: Penny Stocks, What You Need To Know
Receive News & Ratings for Huron Consulting Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huron Consulting Group and related companies with MarketBeat.com's FREE daily email newsletter.